Sex Differences in Genetic Risk for Hypertension
Although it has long been recognized that hypertension prevalence increases with aging in both women and men, recent data have clarified how blood pressure (BP) trajectories differ by sex.1 These differences may contribute to sexual dimorphism in hypertension-related disease outcomes and are likely derived, in part, from genetic origins. Indeed, accumulating evidence indicates that sex bias in gene expression, extending well beyond sex chromosomes, is related to phenotypic variation across organ systems, as well as species.2 Therefore, in a large population-wide cohort comprised almost equally of females and males, we conducted a comprehensive a priori sex-specific genome-wide analysis of single-nucleotide polymorphisms to further elucidate the genetic architecture underlying sex differences in BP elevation.
Our study sample comprised 218 792 genotyped Finnish individuals from FinnGen Data Freeze 5.3 For each participant, biospecimen-derived genotype data were linked to clinical data provided by nationwide hospital medical records and death register records (follow-up period, 1969–2018), as described previously.3 Sex-specific systolic BP polygenic risk scores (PRSs) were calculated using UK Biobank sex-specific genome-wide association study summary statistics for systolic BP on 1 098 015 single-nucleotide polymorphisms and a PRS continuous shrinkage pipeline.3 We used Cox proportional hazards models to assess the association between the PRS and hypertension separately in women and men. Age was considered the timescale, and we used collection year, genotyping batch, and the first 10 genetic principal components as covariates in all models. We considered 2-tailed P<0.05 as statistically significant and used R v.4.0.2 for all analyses.
Our study sample consisted of 218 792 individuals (56% women; mean age at end of follow-up, 58±11 years), including 123 579 women and 95 213 men with 27 804 and 28 113 cases of incident hypertension, respectively. We observed 27 361 cases of early-onset hypertension (age, <55 years) and 28 556 cases of late-onset hypertension.
The PRS was more profoundly associated with hypertension in women than in men, particularly in the highest and in the lowest ranges of PRS (Table). The hazard ratios (HRs) per 1-SD increase in the overall PRS were 1.42 (95% CI, 1.40–1.44) in women and 1.27 (95% CI, 1.26–1.29) in men, with P for interaction of 4×10−29. This sex difference was especially pronounced for relations of PRS with early-onset hypertension (manifesting at age <55 years; HR: 1.56 [95% CI, 1.53–1.58] for women and 1.35 [95% CI, 1.32–1.37] for men; P for interaction, 1×10−28; Table). For late-onset hypertension, the corresponding HRs were 1.31 (95% CI, 1.28–1.33) for women and 1.21 (95% CI, 1.19–1.23) for men (P for interaction, 2×10−9).
| PRS | Women | Men | Interaction P value | ||||
|---|---|---|---|---|---|---|---|
| Cases/controls | HR (95% CI) | P value | Cases/controls | HR (95% CI) | P value | ||
| Any hypertension | |||||||
| <2.5% | 340/2749 | 0.41 (0.37–0.45) | 8×10−60 | 485/1896 | 0.61 (0.56–0.67) | 5×10−26 | 9×10−08 |
| 2.5%–20% | 3401/18 221 | 0.64 (0.61–0.66) | 1×10−126 | 3966/12 694 | 0.75 (0.72–0.77) | 2×10−61 | 1×10−08 |
| 20%–80% | 16 510/57 621 | 1 (referent) | … | 16 661/40 456 | 1 (referent) | … | … |
| 80%–97.5% | 6451/15 172 | 1.52 (1.48–1.57) | 7×10−177 | 5978/10 683 | 1.37 (1.33–1.41) | 3×10−94 | 1×10−05 |
| >97.5% | 1102/1987 | 2.12 (1.99–2.25) | 2×10−126 | 1023/1358 | 1.80 (1.69–1.92) | 5×10−74 | 0.003 |
| Early-onset hypertension (age of onset <55 y) | |||||||
| <2.5% | 111/2979 | 0.33 (0.28–0.40) | 2×10−30 | 213/2168 | 0.60 (0.53–0.69) | 4×10−13 | 1×10−06 |
| 2.5%–20% | 1236/20 389 | 0.54 (0.50–0.57) | 3×10−91 | 1706/14 955 | 0.70 (0.66–0.74) | 1×10−40 | 2×10−10 |
| 20%–80% | 7612/66 530 | 1 (referent) | … | 8150/48 974 | 1 (referent) | … | … |
| 80%–97.5% | 3618/18 007 | 1.71 (1.65–1.78) | 2×10−153 | 3353/13 309 | 1.47 (1.41–1.53) | 8×10−77 | 5×10−07 |
| >97.5% | 702/2387 | 2.51 (2.32–2.72) | 7×10−119 | 660/1721 | 2.10 (1.94–2.28) | 2×10−74 | 0.005 |
| Late-onset hypertension (age of onset ≥55 y) | |||||||
| <2.5% | 229/2860 | 0.46 (0.40–0.52) | 2×10−31 | 272/2109 | 0.62 (0.55–0.70) | 9×10−15 | 0.002 |
| 2.5%–20% | 2165/19 458 | 0.71 (0.68–0.74) | 1×10−45 | 2260/14 401 | 0.78 (0.75–0.82) | 1×10−24 | 0.005 |
| 20%–80% | 8898/65 238 | 1 (referent) | … | 8511/48 609 | 1 (referent) | … | … |
| 80%–97.5% | 2833/18 791 | 1.34 (1.28–1.39) | 3×10−40 | 2625/14 036 | 1.26 (1.21–1.32) | 4×10−25 | 0.1 |
| >97.5% | 400/2690 | 1.66 (1.50–1.84) | 5×10−23 | 363/2018 | 1.45 (1.30–1.61) | 7×10−12 | 0.09 |
We used the Cox proportional hazards models to estimate HRs within categories of the sex-specific genetic risk score for blood pressure. We used age as the timescale and adjusted models for the collection year, genotyping batch, and the first 10 genetic principal components. HR indicates hazard ratio; and PRS, polygenic risk score.
In our study sample of over 200 000 individuals followed for almost 5 decades, we found that sex-specific genetic risk traits are more profoundly associated with risk for hypertension in women than in men and particularly early-onset hypertension. In effect, our results demonstrate that the presence of a low genetic burden offered more protection from hypertension in women than in men.
Numerous prior studies have reported on polygenic risk traits in relation to hypertension in large cohorts.4 Recently, compelling evidence has demonstrated the role of sex-biased gene expression across all chromosomes in determining phenotypic variation across organ systems.2 Thus, given the increasing recognition of sex differences in BP traits, we derived sex-specific PRSs. Our results are distinct from sex-agnostic measures of genetic risk demonstrating no substantial sex differences in relation to outcomes.5
Early-onset hypertension has been related to elevated risk for cardiovascular death, and females have a more accelerated rise in BP with aging, a greater sensitivity of BP elevation to the presence of cardiometabolic traits, and higher level of risk for cardiovascular outcomes for a given elevation of BP.1 This suggests that genetic risk traits for hypertension exert effects that are not only more pronounced in women than men but also have repercussions extending to hypertension-related outcomes. Notably, the genetic risk traits studied were not related to loci on sex chromosomes, by convention, which underscores the relative independence of effects from gonadal traits.
Regarding potential limitations, our study sample included data from hospital biobanks and patient cohorts, which can lead to overestimates of absolute risk. In addition, the participants’ menopausal status was not available. As in most genome-wide studies, we analyzed only autosomal variants. Furthermore, our sample comprised only individuals of European ancestry.
In conclusion, we found evidence of a sex-specific genetic burden of risk for hypertension, particularly early-onset hypertension, that is more pronounced in women than in men. These findings may help to inform clinicians around approaches to communicating with female and male patients with hypertension, prioritizing pharmacotherapy versus lifestyle interventions for managing BP elevation and considering the potential utility of genetic risk screening tools in the future.
Acknowledgments
We thank the participants and investigators of the FinnGen and UK Biobank studies for their invaluable contributions to this work.
References
1.
Ji H, Kim A, Ebinger JE, Niiranen TJ, Claggett BL, Bairey Merz CN, Cheng S. Sex differences in blood pressure trajectories over the life course. JAMA Cardiol. 2020;5:19–26. doi: 10.1001/jamacardio.2019.5306
2.
Naqvi S, Godfrey AK, Hughes JF, Goodheart ML, Mitchell RN, Page DC. Conservation, acquisition, and functional impact of sex-biased gene expression in mammals. Science. 2019;365:eaaw7317. doi: 10.1126/science.aaw7317
3.
Vaura F, Kauko A, Suvila K, Havulinna AS, Mars N, Salomaa V, FinnGen, Cheng S, Niiranen T. Polygenic risk scores predict hypertension onset and cardiovascular risk. Hypertension. 2021;77:1119–1127. doi: 10.1161/HYPERTENSIONAHA.120.16471
4.
Giri A, Hellwege JN, Keaton JM, Park J, Qiu C, Warren HR, Torstenson ES, Kovesdy CP, Sun YV, Wilson OD, et al; Understanding Society Scientific Group; International Consortium for Blood Pressure; Blood Pressure-International Consortium of Exome Chip Studies; Million Veteran Program. Trans-ethnic association study of blood pressure determinants in over 750,000 individuals. Nat Genet. 2019;51:51–62. doi: 10.1038/s41588-018-0303-9
5.
Oikonen M, Tikkanen E, Juhola J, Tuovinen T, Seppälä I, Juonala M, Taittonen L, Mikkilä V, Kähönen M, Ripatti S, et al. Genetic variants and blood pressure in a population-based cohort: the cardiovascular risk in young finns study. Hypertension. 2011;58:1079–1085. doi: 10.1161/HYPERTENSIONAHA.111.179291
Information & Authors
Information
Published In
Copyright
© 2021 American Heart Association, Inc.
Versions
You are viewing the most recent version of this article.
History
Published online: 15 August 2021
Published in print: October 2021
Keywords
Subjects
Authors
Disclosures
None.
Sources of Funding
This work has been funded by the Academy of Finland (321351), the Finnish Foundation for Cardiovascular Research, the Paavo Nurmi Foundation, the Finnish Medical Foundation, the Emil Aaltonen Foundation, the Hospital District of Southwest Finland, and the National Institutes of Health grants R01-HL134168, R01-HL131532, R01-HL143227, R01-HL142983, K23-HL153888, and U54-AG065141.
Metrics & Citations
Metrics
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
- Exploring sex differences: insights into gene expression, neuroanatomy, neurochemistry, cognition, and pathology, Frontiers in Neuroscience, 18, (2024).https://doi.org/10.3389/fnins.2024.1340108
- 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association, Circulation, 149, 8, (e347-e913), (2024)./doi/10.1161/CIR.0000000000001209
- Genetic background influences arterial vasomotor function in male and female mice, Physiological Reports, 11, 19, (2023).https://doi.org/10.14814/phy2.15824
- Sex Differences in the Association of Genome-Wide Systolic Blood Pressure Polygenic Risk Score With Hypertension, Circulation: Genomic and Precision Medicine, 16, 6, (e004259), (2023)./doi/10.1161/CIRCGEN.123.004259
- Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association, Circulation, 147, 8, (e93-e621), (2023)./doi/10.1161/CIR.0000000000001123
- Polygenic risk scores associate with blood pressure traits across the lifespan, European Journal of Preventive Cardiology, 31, 6, (644-654), (2023).https://doi.org/10.1093/eurjpc/zwad365
- Sex-specific differences in the genetic and environmental effects on cardiac phenotypic variation assessed by echocardiography, Scientific Reports, 13, 1, (2023).https://doi.org/10.1038/s41598-023-32577-6
- Gene-based association study reveals a distinct female genetic signal in primary hypertension, Human Genetics, 142, 7, (863-878), (2023).https://doi.org/10.1007/s00439-023-02567-9
- Sex Differences in Myocardial and Vascular Aging, Circulation Research, 130, 4, (566-577), (2022)./doi/10.1161/CIRCRESAHA.121.319902
- Genetic, Molecular, and Cellular Determinants of Sex-Specific Cardiovascular Traits, Circulation Research, 130, 4, (611-631), (2022)./doi/10.1161/CIRCRESAHA.121.319891
Loading...
View Options
Get Access
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
Purchase this article to access the full text.
eLetters(0)
eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.
Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.